Improving healing of the cornea to prevent blindness
Optimizing c-Met signaling to enhance corneal epithelial homeostasis
This study is looking at how to help the surface of the eye heal better, which is important for preventing vision loss, and it aims to find new ways to support healing for people with eye injuries or damage.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11082967 on NIH RePORTER |
What this research studies
This research focuses on enhancing the healing process of the corneal epithelium, which is crucial for preventing corneal blindness, a major global health issue. The project investigates the role of c-Met signaling and its ligand, hepatocyte growth factor, in promoting cell growth and repair in the cornea. By understanding how to optimize this signaling pathway, the research aims to develop new therapeutic strategies that could improve corneal wound healing and maintain epithelial integrity. This could lead to better outcomes for patients suffering from corneal damage due to various causes, including trauma and certain medical treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with corneal epithelial damage due to trauma, surgery, or the effects of anti-cancer drugs.
Not a fit: Patients with corneal issues unrelated to epithelial damage or those with advanced corneal disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve corneal healing and reduce the incidence of blindness.
How similar studies have performed: While the approach of targeting c-Met signaling is promising, it is relatively novel and has not been extensively tested in the context of corneal healing.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Tarvestad Laise, Kate — University of Louisville
- Study coordinator: Tarvestad Laise, Kate
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.